Evidence map›Paper›PMID 36551695›Full record

ArticleCancers2022

Prostate-Specific Membrane Antigen Targeted Pet/CT Imaging in Patients with Colon, Gastric and Pancreatic Cancer.

Floris A Vuijk, Fleur Kleiburg, Wyanne A Noortman, Linda Heijmen, Shirin Feshtali Shahbazi, Floris H P van Velden, Victor M Baart, Shadhvi S Bhairosingh, Bert D Windhorst, Lukas J A C Hawinkels and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Trial
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Floris A VuijkDepartment of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0001-7888-924X
Fleur KleiburgDepartment of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0003-4757-8777
Wyanne A NoortmanDepartment of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Linda HeijmenDepartment of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Shirin Feshtali ShahbaziDepartment of Radiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Floris H P van VeldenDepartment of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Victor M BaartDepartment of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Shadhvi S BhairosinghDepartment of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Bert D WindhorstDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Location VUmc, 1081 HV Amsterdam, The Netherlands.
Lukas J A C HawinkelsDepartment of Gastroenterology and Hepatology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Petra Dibbets-SchneiderDepartment of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Neanke BouwmanDepartment of Clinical Pharmacology and Toxicology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Stijn A L P CrobachDepartment of Pathology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Arantza Fariña-SarasquetaDepartment of Pathology, Amsterdam University Medical Center, Location AMC, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0002-4307-1568
Andreas W K S MarinelliDepartment of Surgery, Haaglanden Medical Center, 2512 VA The Hague, The Netherlands.
Daniela E Oprea-LagerDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Location VUmc, 1081 HV Amsterdam, The Netherlands.
Rutger-Jan SwijnenburgDepartment of Surgery, Amsterdam UMC, Location Vrije Universiteit, 1081 HV Amsterdam, The Netherlands.
Frits SmitDepartment of Radiology, Alrijne Hospital, 2353 GA Leiderdorp, The Netherlands.
Alexander L VahrmeijerDepartment of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Lioe-Fee de Geus-OeiDepartment of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0003-1817-2743
Denise E HillingDepartment of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Marije SlingerlandDepartment of Medical Oncology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

Funding

European Research Council (ERC) Advanced Grant no. 323105the Dutch Cancer Society (KWF) Bas Mulder Award No. UL 2015-7966, dr. D.E. Hillingthe KWF Young Investigators Grant No. 11289, dr. R.J. Swijnenburgthe Leiden University Fund No. W19302-2-62, dr. M. Slingerland
6 · The paper itself

Abstract

Current imaging modalities frequently misjudge disease stage in colorectal, gastric and pancreatic cancer. As treatment decisions are dependent on disease stage, incorrect staging has serious consequences. Previous preclinical research and case reports indicate that prostate-specific membrane antigen (PSMA)-targeted PET/CT imaging might provide a solution to some of these challenges. This prospective clinical study aims to assess the feasibility of [

Indexed as

colon cancergastric cancerpancreatic cancerPET/CTPSMA

Identifiers

PMID36551695
PMCPMC9777210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.